ELI LILLY & Co — Director's Dealing 2023

Oct 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-10-11

Reporting Person: LILLY ENDOWMENT INC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-11	Common Stock	S	37835	$603.243	Disposed	99945975	Direct
2023-10-11	Common Stock	S	29842	$604.397	Disposed	99916133	Direct
2023-10-11	Common Stock	S	74203	$605.412	Disposed	99841930	Direct
2023-10-11	Common Stock	S	51998	$606.747	Disposed	99789932	Direct
2023-10-11	Common Stock	S	21122	$607.743	Disposed	99768810	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $603.00 to $603.94, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $604.00 to $604.94, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.27 to $606.1522, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.31 to $607.27, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.3698 to $608.20, inclusive.